RX-108
N/A
Report date: 2026/05/22 20:01:29
NME
Base Information
Drug NameRX-108
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[4]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesSuzhou Neupharma Co Ltd
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesSuzhou Neupharma Co Ltd
Inactive CompaniesNeupharma, Inc
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A